Syndax Pharmaceuticals Inc (SNDX) — Long-term Investment Intensity
Syndax Pharmaceuticals Inc (SNDX) has a Long-term Investment Intensity of 3.7% as of September 2025. Long-term investments of $20.15 Million represent 3.7% of total assets of $551.79 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Syndax Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Syndax Pharmaceuticals Inc Long-term Investment Intensity (2017–2024)
This chart shows how Syndax Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2017 to 2024. As of September 2025, the intensity stands at 3.7%, reflecting long-term investments of $20.15 Million against total assets of $551.79 Million USD. Explore debt repayment capacity of Syndax Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Syndax Pharmaceuticals Inc (2017–2024)
The table below presents the year-by-year Long-term Investment Intensity for Syndax Pharmaceuticals Inc from 2017 to 2024, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Syndax Pharmaceuticals Inc (SNDX) market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 16.5% | $119.52 Million | $724.82 Million | ▲ +11.6 pp |
| 2023 | 4.9% | $29.83 Million | $612.88 Million | ▲ +3.8 pp |
| 2022 | 1.1% | $5.47 Million | $497.24 Million | ▼ -1.3 pp |
| 2017 | 2.4% | $3.25 Million | $137.19 Million | — |